finance.yahoo.com
Twist Bioscience Reports Strong Q1 Results with Revenue Growth Forecasts for 2025
1410+ Words Refined into 6 Facts by AI • 1 source • 4h ago
Show Full Summary
- Twist Bioscience Corporation reported revenues of US$89 million, exceeding expectations.
- Analysts predict revenues of US$376.0 million for 2025, a 14% improvement.
- Prior forecasts estimated revenues of US$373.1 million and losses of US$2.26.
- The consensus price target remains at US$54.59, indicating stable valuation.
- Revenue growth is expected to slow to 19% annualized until 2025.
- Analysts reconfirmed loss per share estimates, emphasizing long-term business prospects.
The sources of this summary are listed below. Click to view.